Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, today announced that its CytoSure^TM Interpret Software can now seamlessly transfer array comparative genomic hybridisation (aCGH) aberration data directly to Cartagenia's Bench^TM constitutional cytogenetics platform. This helps cytogeneticists accurately correlate genotypic findings with known clinical phenotypes. Further details of this new functionality will be presented in two workshops at the European Human Genetics Conference 2010 in Gothenburg, Sweden, 12-15 June. On 12 June, OGT will present "From disease to cytogenetics research - An integrated CNV analysis platform from Oxford Gene Technology" at 12.00 in room H1. Following on from this at 14.00 in room R4, Cartagenia will present "Routine clinical interpretation of copy number variation".

With the ability to automatically detect CNV aberrations, generates reliable and reproducible results, which can be cross referenced with external aberration databases for accurate data interpretation. These results can now be effortlessly transferred to Cartagenia's Bench platform, allowing additional data management options - including quick and secure data sharing within, and across, various research facilities - and support for genotype-phenotype correlation analysis.

OGT and Cartagenia will be exhibiting at ESHG 2010 on booths B-550 and B-632 respectively. More information on OGT's CytoSure products can be found at www.ogt.co.uk/cytosure.

For further information, please contact:

Oxford Gene Technology, Begbroke Science Park, Sandy Lane, Yarnton, Oxford OX5 1PF
T: +44 (0) 1865 856826 ; F: +44 (0) 1865 848684 W: www.ogt.co.uk